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Background: To study the effect of liver volume (LV) in the morbidity and mortality after elective transjugular intrahepatic portosystemic shunt (TIPS).
Methods: A retrospective review was performed in patients admitted for elective TIPS between 2003 and 2009. Eighty patients were included in the
study. LV was measured by computed tomography or magnetic resonance imaging performed 1–3 months prior to the procedure. A possible correlation
between LV and major adverse events [hepatic encephalopathy (HE) requiring hospital admission, increase in >2 points in MELD (Model for End-Stage
Liver Disease) score >18 points, need for emergent orthotopic liver transplantation (OLT) and/or death] within 6 months after TIPS was studied.
Results: MELD score ranged from 7 to 23 (median: 14) prior to, and from 7 to 43 (median: 17) after TIPS. Post-MELD score and severe HE varied
signiﬁcantly with death status in crude analysis. Pre-MELD score and HE were revealed to be signiﬁcant predictors of death from an adjusted logistic
model. No signiﬁcant associations were found when modeling LV in terms of death or HE. LV was signiﬁcantly smaller in patients that underwent OLT
(n ¼ 18) than those who did not undergo OLT after TIPS (n ¼ 62; P ¼ 0.04). Furthermore, the LV of patients who required emergency OLT for liver failure
after TIPS (n ¼ 10), was signiﬁcantly decreased compared to patients that underwent elective TIPS without OLT (P ¼ 0.03).
Conclusion: Overall, LV was not correlated with major adverse events within 6 months after elective TIPS. However, those patients requiring OLT after TIPS
had signiﬁcantly smaller LV than those not requiring OLT after TIPS.
Copyright  2014, Society of Gastrointestinal Intervention. Published by Elsevier. All rights reserved.
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Transjugular intrahepatic portosystemic shunt (TIPS) is a mini-
mally invasive procedure that has mostly replaced surgical porto-
systemic shunts for the treatment of many of the complications of
portal hypertension in patients with liver cirrhosis, including
recurrent variceal bleeding, refractory ascites, and hepatic hydro-
thorax.1 Several models have been used to predict outcomes after
elective TIPS. MELD (Model for End-Stage Liver Disease) score is the
most commonly usedmodel in clinical practice to predict outcomes
after TIPS and it is also used for organ allocation for liver trans-
plantation. Despite many advantages over the Child–Pugh score,
MELD score has some limitations; most prominently, the lack of
accurately predicting mortality in 15–20% of patients with
cirrhosis.2 The search continues for scoring systems to improve
prognostic accuracy. Recent research suggests incorporation of
other parameters such as the serum sodium levels, hepatic vein
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improve the accuracy of prediction of mortality in patients with
well-compensated cirrhosis.2
In patients with cirrhosis, progressive liver failure eventually
leads to liver volume (LV) depletion. A small liver is a well-known
poor prognostic factor in cirrhosis.3 However, LV has not been
studied as a potential predictor of outcomes after elective TIPS. The
purpose of this retrospective series was to assess the potential role
of LV in predicting major adverse events [hepatic encephalopathy
(HE) requiring hospital admission, increase in >2 points in MELD
score >18 points, need for emergent orthotopic liver transplant
(OLT) and/or death] within 6 months after elective TIPS.
Methods
A retrospective review of electronic medical records was per-
formed in patients admitted for elective TIPS in a single tertiary
liver transplant center between 2003 and 2009. Inclusion criteriatonio, TX, USA
Antonio, TX, USA
San Antonio, San Antonio, TX, USA
3 Floyd Curl Drive, San Antonio, TX 78229, USA.
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Fig. 2. Digital subtraction venography after TIPS created with a Viatorr stent graft
shows patents TIPS. The portosystemic gradient decreased from 22 mm Hg to 7 mm
Hg, and the ascites resolved. TIPS ¼ transjugular intrahepatic portosystemic shunt.
Gastrointestinal Intervention 2014 3(2), 93–9794for this study were: (1) elective TIPS for management of compli-
cations of portal hypertension including refractory ascites, hepatic
hydrothorax, hepatorenal syndrome, and/or history of recurrent
variceal bleeding; (2) computed tomography (CT) and or magnetic
resonance imaging (MRI) performed within 3 months of the pro-
cedure; and (3) follow-up available for at least 6 months after the
procedure. Patients receiving TIPS as an emergency procedurewere
excluded. This retrospective study was conducted in compliance
with Institutional Review Board and Health Insurance Portability
and Accountability Act Requirements.
LV was measured using CT (n ¼ 69) or MR (n ¼ 11) images
transferred to a dedicated workstation (Vitrea, Vital Images, Min-
netonka, MN, USA), bymanually outlining the perimeter of the liver
(excluding the gallbladder and inferior vena cava). In four patients
the digital images were not available and LV was obtained from the
radiology report. LV was calculated in cubic centimeters (Fig. 1).
TIPS procedures were performed by three different interven-
tional radiologists with 5 years, 10 years, and 12 years of clinical
experience performing this procedure. Self-expandable 10-mm
Wallstents (Boston Scientiﬁc, Natick, MA, USA) were used prior to
2003 in 17 patients. Thereafter, 10-mm Viatorr stent grafts (W.L.
Gore and Associates, Flagstaff, AZ, USA) were routinely inserted in
63 patients. Portosystemic gradients (PSGs) were measured prior to
and after the procedure (Fig. 2). The MELD score was calculated
using the standard formula:
MELD ¼ 11:2 lnðINRÞ þ 3:78 lnðtotal bilirubinÞ þ 9:57
 lnðcreatinineÞ þ 6:43: (1)
After the procedure, MELD score was calculated using the ﬁrst
available data, usually within 1 month after TIPS. In some cases,Fig. 1. (A) Patient with cirrhosis and refractory ascites. Axial computed tomography
contrast-enhanced image in the portal venous phase shows the patent’s portal vein
and a small liver with moderate ascites. (B) Three-dimensional image of liver volume
reconstruction shows a total liver volume of 882.5 cm3.MELD score was calculated later as all the laboratory data to
calculate the score became available. In patients with acute
decompensation after TIPS, the last MELD score prior to OLT, and/or
death was calculated. Major adverse events after TIPS included: HE
requiring hospital readmission, increase in2 points inMELD score
>18 points, need for emergent OLT, and/or death within 6 months
after TIPS.
Unadjusted contrasts of continuous factors on death status or
transplant status were based on Wilcoxon tests. The signiﬁcance of
unadjusted association between categorical variables was assessed
using Fisher’s exact test. Multivariate logistic regression models
were performed to predict death status in terms of LV with
adjustment for covariates. Those variables with P  0.1 in the crude
analysis were included in the adjusted analysis. All statistical
testing was two-sided with a signiﬁcance level of 5%. SAS version
9.2 (SAS Institute, Cary, NC, USA) was used throughout.
Results
Eighty patients (22 female and 58 male, aged 77–31 years,
median age 51.5 years) were included in this retrospective review
study. Indications for elective TIPS were refractory ascites (n ¼ 59),
recurrent variceal bleeding (n ¼ 15), and HE (n ¼ 6). Eight patients
had OLT prior to the procedure, and TIPS was performed for re-
fractory ascites in all of these patients.
Patient characteristics by death status are shown in Table 1. The
MELD score prior to the procedure ranged from 7 to 23 (median:
14). After the procedure the MELD score ranged from 7 to 43
(median: 17). Post-MELD score varied signiﬁcantly with death
status (living median ¼ 16, dead median ¼ 20; P ¼ 0.004). Twenty-
four patients (34.8%) developed severe HE requiring hospital
admission, with three patients requiring TIPS reduction. The risk of
severe HEwas increased in dead relative to living patients [living 16
(28.6%), dead 8 (61.5%); P ¼ 0.05].
A multivariable logistic regression of death (yes, no) in terms of
MELD score prior to TIPS, age, severe HE, and LV yielded the
following independent predictors: pre-MELD score (odds
ratio¼ 1.29, 95% conﬁdence interval: 1.03–1.61, P¼ 0.03), severe HE
(odds ratio ¼ 5.39, 95% conﬁdence interval: 1.25–23.22, P ¼ 0.02);
age and LV did not contribute signiﬁcantly to the model (Table 2).
Table 1 Patient Characteristics versus Death Status
Alive (n ¼ 65) Dead (n ¼ 15) Total (n ¼ 80) P
Age (y) 0.1*
Median (Q1,Q3) 51 (47, 57) 55 (48, 63) 51.5 (47.5, 58)
Min, Max 31, 69 44, 77 31, 77
Pre PSG3 0.78*
Median (Q1,Q3) 17 (14, 20) 15 (12, 22) 17 (14, 20)
Min, Max 7, 40 9, 34 7, 40
Post PSG 0.52*
Median (Q1,Q3) 6 (4, 8) 7 (5, 9) 6 (4, 8)
Min, Max 1, 20 3, 9 1, 20
Pre MELD score 0.21*
Median (Q1,Q3) 14 (11, 17) 14 (12, 17) 14 (11.5, 17)
Min, Max 7, 20 11, 23 7, 23
Post MELD scorex 0.004*
Median (Q1,Q3) 16 (14, 20) 20 (19, 25) 17 (14, 21)
Min, Max 7, 31 14, 43 7, 43
Transplant within
6 mo, n (%)
0.17y
No 48 (73.8) 14 (93.3) 62 (77.5)
Yes 17 (26.2) 1 (6.7) 18 (22.5)
Stentz, n (%) 1y
Viatorr 49 (77.8) 11 (78.6) 60 (77.9)
Wall 14 (22.2) 3 (21.4) 17 (22.1)
Severe HEjj, n (%) 0.05y
No 40 (71.4) 5 (38.5) 45 (65.2)
Yes 16 (28.6) 8 (61.5) 24 (34.8)
Liver volume 0.49*
Median (Q1,Q3) 1420 (1180,
1850)
1428 (1290,
1794)
1423.5 (1190,
1835.5)
Min, Max 742, 3671 967, 2646 742, 3671
* Wilcoxon test.
y Fisher’s exact test.
z Missing two patients for Alive, one patient for Dead.
x Missing one patient for Alive, one patient for Dead.
jj Missing nine patients for Alive, one patient for Dead.
Table 3 Liver Volume versus Transplant (yes, no)
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patients had already planned liver transplantation before the TIPS
and OLTs were performed when suitable donors became available
(1 of these patients had a previous OLT and was retransplanted).
Elective OLTs were performed 5–120 days (mean: 60 days) after
TIPS. In this group of patients the median MELD score was 16.5
(n ¼ 8) prior to and 19 (n ¼ 7) after TIPS. In 10 patients (12.5%) that
were not yet scheduled to have liver transplant, emergent OLT was
required 17–140 days (mean: 60 days) after TIPS, as a rescue for
liver failure secondary to the procedure. In this subgroup of pa-
tients (n ¼ 10) the median MELD score was 17 prior to and 21 after
TIPS. A positive correlation was found between LV and OLT after
TIPS for all patients. The median LV for patients that did not un-
dergo OLT after TIPS (n ¼ 62) was 1479 cm3, and was 1298 cm3 for
patients undergoing OLT after TIPS (n ¼ 18; P ¼ 0.04). LV was not
signiﬁcantly different between those patients that did not receive
transplantation after TIPS and patients that had planned trans-
plantation after TIPS (n ¼ 8; P ¼ 0.4). However, LV was signiﬁcantly
lower in those patients (n ¼ 10) who required rescue OLT after TIPS
(median: 1168 cm3), than those patients that did not require OLT
after the procedure (P ¼ 0.03; Table 3).Table 2 Death Prediction Using Liver Volume
n ¼ 80, used ¼ 69, AUC ¼ 0.800
OR (95% CI) P*
Age 1.09 (0.99–1.2) 0.08
Severe HE 5.39 (1.25–23.22) 0.02
Liver volume 1.0002 (0.999–1.002) 0.82
Pre-MELD score 1.29 (1.03–1.61) 0.03
AUC, area under the curve; HE, hepatic encephalopathy; MELD, Model for End-stage
Liver Disease; OR, odds ratio.
* Logistic model.Discussion
TIPS is an established procedure for the treatment of severe
complications of portal hypertension. The accepted indications of
elective TIPS include treatment of refractory ascites, recurrent
variceal bleeding, hepatic hydrothorax, and in some selected cases,
hepatorenal syndrome.1,4,5 Refractory ascites, the most common
indication for elective TIPS, is a disabling complication of portal
hypertension with 1-year mortality rates of 50–80%.6 Alternative
treatments are limited to repeat paracentesis, surgical shunts, and
in eligible candidates, OLT.7 Several comparative studies have
demonstrated that TIPS is more effective in controlling refractory
ascites that repeat paracentesis but usually with a higher incidence
of HE.6,8,9 Recent meta-analysis has shown that patients receiving
TIPS had a signiﬁcantly better transplant-free survival at 24months
(49%) than the paracentesis group (35%),10 with TIPS reducing the
need for paracentesis by w50% but increasing the risk of enceph-
alopathy by about twofold.1
TIPS is a safe procedure in experienced hands, however, serious
complications including death can occur; most of the time from
liver failure. Factors that have been associated with increased
mortality after TIPS include renal insufﬁciency with serum creati-
nine >1.5 mg/dL, hyperbilirubinemia >3 mg/dL, advanced age, and
poor response to TIPS.7,11 Several scores have been developed to
predict morbidity and mortality after TIPS. Of all the predictive
scores, the MELD score is the most commonly used in clinical
practice. This score has been validated in patients undergoing
elective TIPS and in patients with end-stage liver disease awaiting a
liver transplant.12,13 A score >18 has been associated with poor
outcomes after elective TIPS with scores >25 considered as a
contraindication for the procedure in elective patients.
Traditional methods for estimation of hepatic functional
reserve, including liver function tests, Child–Pugh classiﬁcation,
and MELD score can have limitations, and some patients may still
develop liver failure after TIPS despite relatively preserved liver
function by laboratory data.2,14 In patients with cirrhosis, progres-
sive liver failure eventually leads to LV depletion, since the hepatic
cells account for 70–80% of the liver parenchyma. A small LV is a
poor prognostic factor in cirrhosis, often gradually decreasing in the
presence of progressive liver disease.3 Theoretically, the estimation
of LV using CT or MRI scans that are commonly obtained in the
work-up of elective TIPS procedures may improve prediction of
liver failure after TIPS, if the liver reserve is further compromised in
patients with advanced cirrhosis and small LV. One potential
advantage of using LV as a predictor is that it is constant and tends
not to vary as much as other parameters in cirrhosis, such those
used in the Child or MELD classiﬁcations.15 Data derived from im-
aging techniques have demonstrated that hepatic functional
reserve is signiﬁcantly correlated with LV.14–17 In patients with
advanced cirrhosis, there is a progressive loss of LV withNo OLT OLT yes OLT planned Rescue P*
OLT performed
Liver volume
n 62 18 8 10
Median
(Q1,Q3)
1478.5 (1248,
2010)
1297.5 (1088,
1622)
1372 (1209,
1773.5)
1167.5 (1053,
1570)
Min, Max 742, 3671 763, 1821 763, 1821 841, 1707
  0.04
  0.4
  0.03
OLT, orthotopic liver transplantation.
* Wilcoxon test.
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liver, enlarging of the hepatic ﬁssures >2 cm, regeneration of liver
nodules, indented contour, and signs of portal hypertension. In the
initial stages of cirrhosis, the left lateral and caudate lobe hyper-
trophied to compensate for the loss of volume of the right and
quadrate lobe, and as the cirrhosis progresses, the whole liver at-
rophies dramatically.14,15 Tu et al14 estimated the hepatic functional
reserve by cirrhosis grading and LV measurement using CT in pa-
tients undergoing liver resection for HCC. They found a signiﬁcant
correlation between CT grades and Child–Pugh classiﬁcation. Ito
et al18 described a MR scoring system based on volume index of the
spleen; volume index of right posterior þ left medial þ left lateral
segments; presence of ascites; and presence of varices and collat-
erals. They found an accuracy of 89% in distinguishing between
clinical Child–Pugh grade A cirrhosis and further grades, with a
sensitivity of 93% and speciﬁcity of 82%.18 Other authors have
described the use of splenic volume to LV ratio as of prognostic
importance in patients with primary biliary cirrhosis and used it as
an index in the diagnosis of liver cirrhosis.19
Accurate preoperative measurement of LV has become an
important tool in predicting the extent of hepatectomy in patients
with liver cancer, estimating hepatic metastatic tumor burden, and
determining segmental LV of donors for living related liver trans-
plantation.3 LV has also been recommended to evaluate liver
reserve function in the setting of acute and chronic liver disease.15
In patients undergoing liver resection, the remnant LV is closely
related to the incidence of complications after liver resection. The
incidence of serious complications after resection is higher in pa-
tients with remaining LV <25%.20
The current use of multidetector CT scanners with faster speed
of data collection and image processing, fewer artifacts from res-
piratory motion and thinner slices allow more accurate three-
dimensional reconstruction images and ﬁner anatomic images
even in patients with signiﬁcant ascites.15 Estimation of LV by CT
scans has proven to be a reliable method to estimate LV with ac-
curacy within 5%.20
Normal LV has been studied in Western populations with an
estimated mean volume of 1531 cm3 (range: 649–3558 cm3).21 In a
study by Shiano et al,3 the CT LV was compared with the recipient
LV at the time of OLT. The median CT LV was 1308 cm3 (range: 338–
3847 cm3) for patients with hepatocellular disease (e.g., viral hep-
atitis, or alcohol-related), 1651 cm3 (range: 641–3861 cm3) for pa-
tients with cholestatic disease (e.g., primary biliary cirrhosis), and
1210 cm3 (range: 348–2575 cm3), for patients with cryptogenic
cirrhosis. In the study by Xiang et al,15 the mean total LV of all pa-
tients with viral hepatitis cirrhosis was signiﬁcantly smaller than
that of the healthy controls with mean LV in Child–Pugh class A, B,
and C patients of 1100.92  336.68 cm3, 1043.88  364.75 cm3 and
798.01  203.64 cm3, respectively.15
In the present study of 80 patients undergoing elective TIPS, the
median LV was 1423.5 cm3 (range: 742–3671 cm3). The smallest
liver in this study was 742 cm3. It is likely that patients with smaller
livers would not have been referred for elective TIPS due to a bias
that deterioration might occur, or the liver dysfunctionwas already
advanced and contraindicated elective TIPS. Other limitations of
this study included its retrospective nature and the limited number
of patients included. The inclusion of eight patients with planned
OLT may also be another limitation because the effect of elective
TIPS in this group of patients is not well known.
In most retrospective and prospective studies, the mortality
rates at 6 months after TIPS ranged from 25% to 50%.7 Fifteen pa-
tients (18.7%) died within 6 months in this series. In the present
study 30% of the patients developed severe HE requiring hospital
admission, with three patients requiring TIPS reduction. This is
consistent with larger series showing a rate of new or worseningHE from 20% to 40%.7 In a logistic model analysis, pre-MELD score
and presence of severe HE after TIPS were predictors of death
within 6 months after the procedure. A crude analysis found that
PSG <8 mm Hg, age, or type of stent had no correlation with
mortality. Other studies also have demonstrated that the presence
of HE affects survival of patients with cirrhosis and patients
receiving TIPS.22 Although other studies have also suggested an
association between PSG <8 mm Hg after TIPS creation with
increased mortality,23 no association was found between PSG prior
to or after TIPS.
In conclusion, a retrospective study of 80 patients undergoing
elective TIPS demonstrated that developing severe HE and
increased MELD score prior to the procedure were factors pre-
dicting early mortality. Although LV had no correlation with
developing major adverse events after elective TIPS, patients
requiring rescue OLT for liver decompensation after the procedure
had lower LV that patients that did not require OLT after TIPS,
suggesting that LV may be a useful prognostic factor for predicting
the need of rescue OLT after elective TIPS. Further studies on the
effect of LV in patients with advanced cirrhosis undergoing elective
TIPS are warranted.
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